Kelly Financial Services LLC Sorrento Therapeutics, Inc. Transaction History

Kelly Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jul 17, 2024	SELL	$0.17 - $1.19 $2,467 - $17,272	-14,515 Closed	0 $0
Q3 2022 Jul 17, 2024	BUY	$1.51 - $2.88 $10,796 - $20,592	7,150 Added 97.08%	14,515 $22.8 Million
Q1 2022 Jul 17, 2024	BUY	$2.0 - $4.9 $6,730 - $16,488	3,365 Added 84.13%	7,365 $17.2 Million
Q3 2021 Jul 17, 2024	SELL	$7.41 - $10.99 $257,571 - $382,012	-34,760 Reduced 89.68%	4,000 $30.5 Million
Q2 2021 Jul 17, 2024	BUY	$6.35 - $10.0 $232,460 - $366,080	36,608 Added 1701.12%	38,760 $4 Million
Q1 2021 Jul 17, 2024	BUY	$7.03 - $16.51 $7,030 - $16,510	1,000 Added 86.81%	2,152 $17.8 Million
Q3 2020 Jul 17, 2024	BUY	$6.17 - $18.82 $7,107 - $21,680	1,152 New	1,152 $12.8 Million

5.45M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Kelly Financial Services LLC with notifications on news.